SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (5)7/22/2006 3:03:05 PM
From: dr.praveen   of 90
 
I had a few doubts reading the same PR about the tgt population. 20% of 45000 SCT pts makes it up to 9000 cases acc to the Company who are likely to get VOD. But if we know before low AT3 levels lead to VOD, so isn't the preventive market lost?

Instead of the 45000pts, it will be now 9000 pts who are likely to get defibrotide. I am not saying that this is not a huge population but isn't it reduced by 1/5th? I haven't done a valuation and the upside estimates since I am not sure how much they will be charging for each pt.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News